Improving time to optimal Staphylococcus aureus treatment using a penicillin-binding protein 2a assay

Area of Science:

• Clinical microbiology
• Antimicrobial resistance
• Diagnostic assays

Background:

• Staphylococcus aureus is a significant pathogen.
• Accurate and rapid methicillin susceptibility testing is crucial for effective treatment.
• Antimicrobial stewardship programs aim to optimize antibiotic use.

Purpose of the Study:

• To evaluate the impact of a penicillin-binding protein 2a (PBP2a) assay on time to optimal therapy for Staphylococcus aureus infections.
• To assess the utility of the PBP2a assay in conjunction with an antimicrobial stewardship intervention.
• To determine the suitability of the PBP2a assay for healthcare facilities with limited resources.

Main Methods:

• A pre-post-study design was employed.
• The penicillin-binding protein 2a (PBP2a) assay was utilized for methicillin susceptibility testing.
• An antimicrobial stewardship intervention was implemented alongside the PBP2a assay.

Main Results:

• The PBP2a assay demonstrated itself to be a quick, accurate, and inexpensive diagnostic tool.
• A significant improvement in the time to optimal therapy for both methicillin-susceptible and methicillin-resistant Staphylococcus aureus isolates was observed.
• The study supported the integration of the PBP2a assay into antimicrobial stewardship programs.

Conclusions:

• The penicillin-binding protein 2a (PBP2a) assay significantly reduces the time to optimal therapy for Staphylococcus aureus infections.
• The PBP2a assay is a valuable tool for antimicrobial stewardship, particularly in resource-limited settings.
• Widespread adoption of the PBP2a assay is recommended for all healthcare facilities.